Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sol-Gel Technologies Ltd.

Latest From Sol-Gel Technologies Ltd.

Deals Shaping The Medical Industry, April 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Sol-Gel Technologies Ltd.

Sol-Gel Technologies' manufacturing process for the encapsulation of bioactive molecules in a bioactive glass under gentle manufacturing conditions has many applications in health care.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Topical Delivery
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Sol-Gel Technologies Ltd.
  • Senior Management
  • Alon Seri-Levy, PhD, CEO
    Ido Zalel, CFO
    Ofer Toledano, VP, R&D
  • Contact Info
  • Sol-Gel Technologies Ltd.
    Phone: (972) 8 9313433
    7 Golda Meir St.
    Ness Ziona, 74036